Today: 31 January 2026
Subscribe
Browse Category

Investing News 8 October 2025

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 Biospace; ~16 patients treated in launch year Nasdaq. Sold to US WorldMeds (2025) Adaptimmune Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase II completed (42% response rate) Stocktitan; FDA Breakthroughdesignation in 2025 Stocktitan; BLA filing planned for 2025. Sold to US WorldMeds (2025) Adaptimmune Uzatresegene…
8 October 2025
····
Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Below, we dive deeper into each of these areas – from Snowflake’s business model and financials to the latest news, analyst insights, competitive dynamics, and what to expect going forward. Company Overview and Business Model Snowflake Inc. is a cloud data platform provider, offering data warehousing as a service alongside a suite of data analytics and sharing capabilities. Unlike traditional databases tied…
8 October 2025
····
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Detailed Report 1. Stock Performance and Valuation Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025 (the last trading day before the U.S. Columbus Day holiday), the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior session Stockinvest. Technical analysts at Stockinvest.us noted the shares were near the upper…
8 October 2025
····
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

Current Stock Price and Performance (Oct 8 2025) UnitedHealth Group’s share price has been volatile in 2025. On 8 Oct 2025 the stock closed around $372—IndMoney quoted $372.93 while Investing.com listed $372.64 Indmoney Investing. Reuters reported that the last trade was $371.46, up 2.15 % from the previous day Reuters. The wide 52‑week range ($234.60‑$630.73) highlights the enormous drawdown from April’s peak and underscores the…
8 October 2025
···
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit’s Rollercoaster: How Booming Ads, AI Deals and Political Scrutiny Could Shock RDDT Investors

Key Facts (as of 8 Oct 2025) Item Detail Sources Current stock price Reddit’s Class A shares traded around $199.54 at 11:58 AM EDT on 8 Oct 2025 with an intraday high of $206.22 and low of $195.01; the official investor‑relations site notes a 52‑week high of $282.95 and low of $69.30 Redditinc. Reddit investor relations Analyst consensus Across 25‑28 analysts the consensus rating is “moderate/buy”.…
8 October 2025
···
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

Introduction: A New Kind of Biotech Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is redefining drug discovery by combining cutting-edge biology and data science. Based in Salt Lake City, this “TechBio” pioneer uses automation, massive datasets and machine learning to identify new therapies faster than traditional labs Directorstalkinterviews Nasdaq. Its mission – “to decode biology to radically improve lives” – has attracted…
8 October 2025
···
Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Company Overview Webull is a digital investment platform that offers commission-free trading of stocks, ETFs, options, cryptocurrencies and more via a popular mobile app and web interface Cmcmarkets. Often likened to Robinhood, Webull makes money primarily through payment for order flow and premium add-on services Cmcmarkets. The platform launched in 2018 and quickly gained traction among tech-savvy retail investors with its sleek…
8 October 2025
···
SoundHound AI Stock Soars 240% – Could This Voice Tech Disruptor Make You a Millionaire?

SoundHound AI Stock Soars 240% – Could This Voice Tech Disruptor Make You a Millionaire?

SOUN Stock Surges on AI Hype and Big News SoundHound AI’s stock has been on a tear in recent months, riding the wave of excitement surrounding artificial intelligence. The company’s share price has climbed roughly 240% over the past year (and more than doubled in the last six months) ts2.tech. Just in the past week, SOUN jumped about 15%, climbing…
8 October 2025
····
Wall Street’s $2 Billion Bet on the Future: NYSE Owner Goes All-In on Polymarket Prediction Markets

Wall Street’s $2 Billion Bet on the Future: NYSE Owner Goes All-In on Polymarket Prediction Markets

ICE’s $2B Vote of Confidence in Polymarket Wall Street’s biggest exchange operator is making a bold bet that betting on real-world events is the next big financial frontier. Intercontinental Exchange Inc. (ICE) – the owner of the NYSE – confirmed it will invest $2 billion in Polymarket, a deal that values the crypto-powered betting platform at roughly $8 billion pre-money…
8 October 2025
····
Silver Near $50 – Is a New Record Imminent? Inside 2025’s Soaring Silver Surge

Silver Near $50 – Is a New Record Imminent? Inside 2025’s Soaring Silver Surge

Silver Soars to 14-Year Highs, Closing in on Record Levels Silver’s price has exploded upward in 2025, putting the vaunted $50 per ounce milestone within sight. As of October 8, 2025, spot silver trades around $48.8/oz Investing – territory not seen since 2011. Just days earlier it touched $47.8, the loftiest price in over 14 years ts2.tech. This puts silver…
8 October 2025
···
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray’s Stock Price Soars on Reform Speculation Tilray’s stock has been on a tear in recent months, staging a stunning turnaround from penny-stock levels. The share price has quadrupled since early July – rising from well under $0.5 to around $1.7 by early October Nasdaq. Year-to-date, TLRY is up ~22% (as of Oct. 8) after being down over 20% mid-year Talkmarkets Hi Plainscoop. This…
8 October 2025
····
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Recent News & Stock Performance (October 2025) Tilray’s stock has been on a wild ride in early October 2025, propelled by a flurry of cannabis policy news. In the first week of October, TLRY jumped over 8% in one day (Oct 7) after an apparent breakthrough in U.S. marijuana reform sentiment Nasdaq Nasdaq. The trigger: several prominent Republican senators voiced…
8 October 2025
····
1 … 519 520 521 522 523 … 532

Stock Market Today

  • NSE and BSE to Open for Rare Sunday Trading During Budget 2026
    January 31, 2026, 9:32 AM EST. The National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) will hold a rare Sunday trading session on February 1, 2026, coinciding with the Union Budget presentation by Finance Minister Nirmala Sitharaman. This is only the second time since Independence that markets will operate on a Sunday, enabling investors to react instantly to policy announcements. Both exchanges will follow standard trading hours, with the pre-open session starting at 9 a.m. Live trading in commodity markets will also occur on this day. Markets approached the session cautiously after gains fueled by the India-EU Free Trade Agreement, although mixed earnings and foreign institutional investor selling limited further upside. Sector gains were seen in defence, energy, and oil and gas, while pharma and FMCG lagged, reflecting uneven investor sentiment ahead of the Budget.
Go toTop